Paclitaxel plus gemcitabine may be as active and well tolerated as paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Chen
Yuh-Min
YM
Chest Department, School of Medicine, National Yang-Ming University, Taipei Veterans General Hospital, Taiwan. ymchen@vghtpe.gov.tw